| vaccinated PCC+ | Vs. | vaccinated PCC- | p-value | |
|---|---|---|---|---|
| BAU/mL – median (IQR) | 7436 (11295) | 7985 (13958) | 0.56 | |
| Nucleocapsid Antibody – median (IQR) | 7.1 (12) | 6.4 (8.9) | 0.35 |
Based upon Mann Whitney; BAU, Binding Antibody Units; IQR, interquartile range
| vaccinated PCC+ | Vs. | vaccinated PCC- | p-value | |
|---|---|---|---|---|
| BAU/mL – median (IQR) | 7436 (11295) | 7985 (13958) | 0.56 | |
| Nucleocapsid Antibody – median (IQR) | 7.1 (12) | 6.4 (8.9) | 0.35 |
Based upon Mann Whitney; BAU, Binding Antibody Units; IQR, interquartile range